Lyman GH - Search Results

1

Anthracyclines in the treatment of early-stage breast cancer: ally or adversary?

Lyman GH. Lyman GH. Cancer Invest. 2010 Mar;28(3):217-9. doi: 10.3109/07357901003640404. Cancer Invest. 2010. PMID: 20128683 No abstract available.

2

Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.

Lyman GH, Delgado DJ. Lyman GH, et al. Cancer. 2003 Dec 1;98(11):2402-9. doi: 10.1002/cncr.11827. Cancer. 2003. PMID: 14635075 Free article.

3

A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.

Lyman GH, Green SJ, Ravdin PM, Geyer CE Jr, Russell CA, Balcerzak SP, Thomas Budd G, Martino S; Southwest Oncology Group Randomized Phase II Study. Lyman GH, et al. Breast Cancer Res Treat. 2004 May;85(2):143-50. doi: 10.1023/B:BREA.0000025405.63953.f9. Breast Cancer Res Treat. 2004. PMID: 15111772 Clinical Trial.

4

Are there clinical benefits with early erythropoietic intervention for chemotherapy-induced anemia? A systematic review.

Lyman GH, Glaspy J. Lyman GH, et al. Cancer. 2006 Jan 1;106(1):223-33. doi: 10.1002/cncr.21570. Cancer. 2006. PMID: 16331597 Free article. Review.

5

Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis.

Lyman GH, Kuderer NM. Lyman GH, et al. Clin Breast Cancer. 2006 Dec;7(5):372-9. doi: 10.3816/CBC.2006.n.053. Clin Breast Cancer. 2006. PMID: 17239261

6

Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.

Lyman GH, Cosler LE, Kuderer NM, Hornberger J. Lyman GH, et al. Cancer. 2007 Mar 15;109(6):1011-8. doi: 10.1002/cncr.22506. Cancer. 2007. PMID: 17311307 Free article.

7

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.

Kuderer NM, Khorana AA, Lyman GH, Francis CW. Kuderer NM, et al. Among authors: lyman gh. Cancer. 2007 Sep 1;110(5):1149-61. doi: 10.1002/cncr.22892. Cancer. 2007. PMID: 17634948 Free article. Review.

8

Cancer and thrombosis: back to the future renewed interest in an old problem.

Lyman GH, Khorana AA, Kuderer NM, Lee AY. Lyman GH, et al. Cancer Invest. 2009 Jun;27(5):472-3. doi: 10.1080/07357900902996441. Cancer Invest. 2009. PMID: 19479483

9

Comparative effectiveness research in oncology: the need for clarity, transparency and vision.

Lyman GH. Lyman GH. Cancer Invest. 2009 Jul;27(6):593-7. doi: 10.1080/07357900903109952. Cancer Invest. 2009. PMID: 19557579 No abstract available.

10

Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.

Shayne M, Culakova E, Wolff D, Poniewierski MS, Dale DC, Crawford J, Lyman GH. Shayne M, et al. Among authors: lyman gh. Cancer. 2009 Nov 15;115(22):5319-28. doi: 10.1002/cncr.24560. Cancer. 2009. PMID: 19672945 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters